Editorial: Prebiotics in the management of obesity and associated metabolic disorders
Sepehr Khosravi,
Ozra Tabatabaei-Malazy,
Ozra Tabatabaei-Malazy,
Solaleh Emamgholipour,
Solaleh Emamgholipour,
Mozhdeh Sojoodi,
Parisa Shabani
Affiliations
Sepehr Khosravi
Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
Ozra Tabatabaei-Malazy
Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
Ozra Tabatabaei-Malazy
Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
Solaleh Emamgholipour
Department of Clinical Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Solaleh Emamgholipour
Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
Mozhdeh Sojoodi
Division of Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
Parisa Shabani
Frankel Institute For Heart and Brain Health, University of Michigan, Medial Center, Ann Arbor, MI, United States
